Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-24 · accession 0001209191-23-013722 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-28 | 2023-02-24 | DLB | Sud Anjali | Dir | S - Sale | $82.00 | -8,873 | 6,079 | -59% | -$727.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-24 | S | D | 8,873 | $82.00 | 6,079 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $81.98 to $82.005. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F2) Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest. |